|
OMIM |
Link |
Information gain |
01 |
|
apnea, obstructive sleep
|
[NCBI]
|
0.00501411
|
|
|
MDD
|
[NCBI]
|
0.00165333
|
|
|
CD
|
[NCBI]
|
0.00142082
|
|
|
SLE
|
[NCBI]
|
0.00130615
|
|
|
MYP2
|
[NCBI]
|
0.0010249
|
|
|
abdominal obesity-metabolic syndrome
|
[NCBI]
|
0.000876953
|
|
|
cluster headache, familial
|
[NCBI]
|
0.000801364
|
|
|
raynaud disease
|
[NCBI]
|
0.000792943
|
|
|
plasmodium falciparum fever episodes quantitative trait locus 1
|
[NCBI]
|
0.000792943
|
|
|
mycobacterium tuberculosis, susceptibility to, 1
|
[NCBI]
|
0.000792943
|
|
|
OPA5
|
[NCBI]
|
0.000792943
|
|
|
migraine with or without aura, susceptibility to, 1
|
[NCBI]
|
0.000694584
|
|
|
BULN1
|
[NCBI]
|
0.000654288
|
|
|
kabuki syndrome
|
[NCBI]
|
0.000550279
|
|
|
thyroid carcinoma, papillary, with papillary renal neoplasia
|
[NCBI]
|
0.00053077
|
|
|
thyroid carcinoma, nonmedullary 1
|
[NCBI]
|
0.00053077
|
|
|
esophagitis, eosinophilic
|
[NCBI]
|
0.00053077
|
|
|
FTSD
|
[NCBI]
|
0.00053077
|
|
|
leprosy, susceptibility to, 1
|
[NCBI]
|
0.000433709
|
|
|
ATFB1
|
[NCBI]
|
0.000433709
|
|
|
kala-azar, susceptibility to, 1
|
[NCBI]
|
0.000371746
|
|
|
speech-sound disorder
|
[NCBI]
|
0.000371746
|
|
|
asperger syndrome, susceptibility to, 1
|
[NCBI]
|
0.000371746
|
|
|
opioid dependence, susceptibility to, 1
|
[NCBI]
|
0.000371746
|
|
|
nipples, supernumerary
|
[NCBI]
|
0.000371746
|
|
|
G6PD
|
[NCBI]
|
0.000370258
|
|
|
torus palatinus and torus mandibularis
|
[NCBI]
|
0.000326451
|
|
|
OPA4
|
[NCBI]
|
0.000326451
|
|
|
restless legs syndrome, susceptibility to, 1
|
[NCBI]
|
0.000311082
|
|
|
HFM
|
[NCBI]
|
0.000297285
|
|
|
microtia-anotia
|
[NCBI]
|
0.000290975
|
|
|
EOCA
|
[NCBI]
|
0.000290975
|
|
|
jejunal atresia
|
[NCBI]
|
0.000290975
|
|
|
precocious puberty
|
[NCBI]
|
0.000290975
|
|
|
vestibulopathy, familial
|
[NCBI]
|
0.000290975
|
|
|
maxillonasal dysplasia, binder type
|
[NCBI]
|
0.000261986
|
|
|
thyroid carcinoma, nonmedullary, with or without cell oxyphilia
|
[NCBI]
|
0.000261986
|
|
|
MNG1
|
[NCBI]
|
0.000261986
|
|
|
DFN2
|
[NCBI]
|
0.000237607
|
|
|
ANON1
|
[NCBI]
|
0.000237607
|
|
|
prostate cancer, hereditary, 8
|
[NCBI]
|
0.000237607
|
|
|
CTS1
|
[NCBI]
|
0.000237607
|
|
|
PTH
|
[NCBI]
|
0.000231849
|
|
|
constricting bands, congenital
|
[NCBI]
|
0.000216677
|
|
|
behcet syndrome
|
[NCBI]
|
0.000212587
|
|
|
dermatitis, atopic
|
[NCBI]
|
0.000198423
|
|
|
HPCX
|
[NCBI]
|
0.000198423
|
|
|
GBD1
|
[NCBI]
|
0.000175993
|
|
|
anencephaly
|
[NCBI]
|
0.000167939
|
|
|
poland syndrome
|
[NCBI]
|
0.000167939
|
|
|
KLK3
|
[NCBI]
|
0.000165526
|
|
|
VRNI
|
[NCBI]
|
0.000161155
|
|
|
GTS
|
[NCBI]
|
0.000157436
|
|
|
HFE
|
[NCBI]
|
0.000156246
|
|
|
IBGC1
|
[NCBI]
|
0.000155026
|
|
|
CPI
|
[NCBI]
|
0.000151784
|
|
|
glaucoma, normal tension, susceptibility to
|
[NCBI]
|
0.000149133
|
|
|
EGF
|
[NCBI]
|
0.000147972
|
|
|
alopecia, androgenetic
|
[NCBI]
|
0.000143024
|
|
|
IS1
|
[NCBI]
|
0.000142881
|
|
|
APOE
|
[NCBI]
|
0.000142224
|
|
|
twinning, dizygotic
|
[NCBI]
|
0.000132715
|
|
|
PAND1
|
[NCBI]
|
0.000132715
|
|
|
alopecia areata 1
|
[NCBI]
|
0.000132715
|
|
|
FMF
|
[NCBI]
|
0.000132103
|
|
|
aortic valve disease
|
[NCBI]
|
0.000125243
|
|
|
MTHFR
|
[NCBI]
|
0.000123356
|
|
|
PD
|
[NCBI]
|
0.000122573
|
|
|
MYOC
|
[NCBI]
|
0.000110959
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
0.000107101
|
|
|
RA
|
[NCBI]
|
0.000102628
|
|
|
SACS
|
[NCBI]
|
9.98548e-05
|
|
|
NF1
|
[NCBI]
|
9.95138e-05
|
|
|
polydactyly, preaxial i
|
[NCBI]
|
9.94101e-05
|
|
|
MCDR1
|
[NCBI]
|
9.12697e-05
|
|
|
chiari malformation type i
|
[NCBI]
|
9.12697e-05
|
|
|
VEGF
|
[NCBI]
|
8.82385e-05
|
|
|
scleroderma, familial progressive
|
[NCBI]
|
8.47515e-05
|
|
|
ALD
|
[NCBI]
|
8.32097e-05
|
|
|
HHT
|
[NCBI]
|
8.08164e-05
|
|
|
autism
|
[NCBI]
|
7.89605e-05
|
|
|
cleft lip, congenital healed
|
[NCBI]
|
7.704e-05
|
|
|
PPAB
|
[NCBI]
|
7.704e-05
|
|
|
LGMD2A
|
[NCBI]
|
7.65849e-05
|
|
|
CVS
|
[NCBI]
|
7.65849e-05
|
|
|
FA
|
[NCBI]
|
7.43763e-05
|
|
|
LAM
|
[NCBI]
|
7.4246e-05
|
|
|
LDLR
|
[NCBI]
|
7.30472e-05
|
|
|
hashimoto thyroiditis
|
[NCBI]
|
7.30429e-05
|
|
|
PG
|
[NCBI]
|
7.30193e-05
|
|
|
AT
|
[NCBI]
|
7.24538e-05
|
|
|
hypospadias, autosomal
|
[NCBI]
|
7.23528e-05
|
|
|
GJB2
|
[NCBI]
|
6.91074e-05
|
|
|
CAPN3
|
[NCBI]
|
6.78217e-05
|
|
|
MTRNR1
|
[NCBI]
|
6.78217e-05
|
|
|
LRRK2
|
[NCBI]
|
6.63186e-05
|
|
|
factor v deficiency
|
[NCBI]
|
6.33772e-05
|
|
|
BWS
|
[NCBI]
|
6.29743e-05
|
|
|
HCRTR2
|
[NCBI]
|
6.17811e-05
|
|
|
iron overload in africa
|
[NCBI]
|
6.16085e-05
|
|
|
WAS
|
[NCBI]
|
6.11715e-05
|
|
|
thyroid carcinoma, papillary
|
[NCBI]
|
5.41108e-05
|
|
|
SCA6
|
[NCBI]
|
5.41108e-05
|
|
|
FRNS
|
[NCBI]
|
5.39471e-05
|
|
|
adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency
|
[NCBI]
|
5.30545e-05
|
|
|
ALB
|
[NCBI]
|
5.0908e-05
|
|
|
CJD
|
[NCBI]
|
5.02233e-05
|
|
|
GRA
|
[NCBI]
|
5.01184e-05
|
|
|
sarcoidosis
|
[NCBI]
|
5.00966e-05
|
|
|
uric acid nephrolithiasis, susceptibility to
|
[NCBI]
|
4.9699e-05
|
|
|
kifafa seizure disorder
|
[NCBI]
|
4.9699e-05
|
|
|
teeth present at birth
|
[NCBI]
|
4.9699e-05
|
|
|
periodontitis, chronic
|
[NCBI]
|
4.9699e-05
|
|
|
apert syndrome
|
[NCBI]
|
4.91607e-05
|
|
|
ADHD
|
[NCBI]
|
4.91061e-05
|
|
|
DHFR
|
[NCBI]
|
4.74628e-05
|
|
|
XFS
|
[NCBI]
|
4.70339e-05
|
|
|
TG
|
[NCBI]
|
4.63014e-05
|
|
|
fragile x mental retardation syndrome
|
[NCBI]
|
4.58922e-05
|
|
|
LPL
|
[NCBI]
|
4.50572e-05
|
|
|
PNDM
|
[NCBI]
|
4.42524e-05
|
|
|
FSCN2
|
[NCBI]
|
4.32433e-05
|
|
|
DWS
|
[NCBI]
|
4.25916e-05
|
|
|
GCK
|
[NCBI]
|
4.24578e-05
|
|
|
OPTN
|
[NCBI]
|
4.20984e-05
|
|
|
ARMD1
|
[NCBI]
|
4.09736e-05
|
|
|
BRAF
|
[NCBI]
|
4.00016e-05
|
|
|
arcus corneae
|
[NCBI]
|
3.96487e-05
|
|
|
siderius x-linked mental retardation syndrome
|
[NCBI]
|
3.96487e-05
|
|
|
MODY8
|
[NCBI]
|
3.96487e-05
|
|
|
meniere disease
|
[NCBI]
|
3.96487e-05
|
|
|
PXE
|
[NCBI]
|
3.95484e-05
|
|
|
APOB
|
[NCBI]
|
3.75357e-05
|
|
|
danubian endemic familial nephropathy
|
[NCBI]
|
3.7369e-05
|
|
|
APS1
|
[NCBI]
|
3.58894e-05
|
|
|
F2
|
[NCBI]
|
3.52536e-05
|
|
|
TPO
|
[NCBI]
|
3.39941e-05
|
|
|
CELIAC4
|
[NCBI]
|
3.32738e-05
|
|
|
sarcoidosis, early-onset
|
[NCBI]
|
3.32738e-05
|
|
|
leprosy, susceptibility to, 2
|
[NCBI]
|
3.32738e-05
|
|
|
ascaris lumbricoides infection, susceptibility to
|
[NCBI]
|
3.32738e-05
|
|
|
coronary heart disease, susceptibility to, 5
|
[NCBI]
|
3.32738e-05
|
|
|
TSD
|
[NCBI]
|
3.28671e-05
|
|
|
pyruvate kinase deficiency of red cells
|
[NCBI]
|
3.25704e-05
|
|
|
CCK
|
[NCBI]
|
3.18287e-05
|
|
|
stroke, ischemic
|
[NCBI]
|
3.16213e-05
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-positive
|
[NCBI]
|
3.16213e-05
|
|
|
MC4R
|
[NCBI]
|
3.13659e-05
|
|
|
CLCN5
|
[NCBI]
|
3.03688e-05
|
|
|
MTR
|
[NCBI]
|
2.94273e-05
|
|
|
DMD
|
[NCBI]
|
2.93119e-05
|
|
|
PCNA
|
[NCBI]
|
2.93044e-05
|
|
|
EGFR
|
[NCBI]
|
2.90415e-05
|
|
|
VHL
|
[NCBI]
|
2.86498e-05
|
|
|
ODG1
|
[NCBI]
|
2.86445e-05
|
|
|
CVG/MR
|
[NCBI]
|
2.86445e-05
|
|
|
epidermolysis bullosa pruriginosa
|
[NCBI]
|
2.86445e-05
|
|
|
isoproterenol-mediated vasodilatation
|
[NCBI]
|
2.86445e-05
|
|
|
KRS
|
[NCBI]
|
2.86445e-05
|
|
|
AIHHT
|
[NCBI]
|
2.86445e-05
|
|
|
young syndrome
|
[NCBI]
|
2.86445e-05
|
|
|
ACHE
|
[NCBI]
|
2.85689e-05
|
|
|
OPA1
|
[NCBI]
|
2.74769e-05
|
|
|
AVP
|
[NCBI]
|
2.72149e-05
|
|
|
HNF1A
|
[NCBI]
|
2.71757e-05
|
|
|
MJD
|
[NCBI]
|
2.6942e-05
|
|
|
homocystinuria
|
[NCBI]
|
2.68313e-05
|
|
|
VDR
|
[NCBI]
|
2.66896e-05
|
|
|
FABP2
|
[NCBI]
|
2.66597e-05
|
|
|
SMA1
|
[NCBI]
|
2.60593e-05
|
|
|
AIRE
|
[NCBI]
|
2.60038e-05
|
|
|
PPR
|
[NCBI]
|
2.55078e-05
|
|
|
DFSP
|
[NCBI]
|
2.52136e-05
|
|
|
nonarteritic anterior ischemic optic neuropathy, susceptibility to
|
[NCBI]
|
2.50433e-05
|
|
|
gastroschisis
|
[NCBI]
|
2.50433e-05
|
|
|
sarcosinemia
|
[NCBI]
|
2.50433e-05
|
|
|
OCA4
|
[NCBI]
|
2.50433e-05
|
|
|
thrombophilia
|
[NCBI]
|
2.50433e-05
|
|
|
HOA
|
[NCBI]
|
2.50433e-05
|
|
|
PJS
|
[NCBI]
|
2.49035e-05
|
|
|
PDB
|
[NCBI]
|
2.44169e-05
|
|
|
ABCC6
|
[NCBI]
|
2.38936e-05
|
|
|
NCAPG
|
[NCBI]
|
2.36222e-05
|
|
|
ATP13A2
|
[NCBI]
|
2.36222e-05
|
|
|
CHEK2
|
[NCBI]
|
2.33005e-05
|
|
|
ADRB2
|
[NCBI]
|
2.33005e-05
|
|
|
SHOX
|
[NCBI]
|
2.33005e-05
|
|
|
PCOS1
|
[NCBI]
|
2.32509e-05
|
|
|
PKLR
|
[NCBI]
|
2.30159e-05
|
|
|
ATP7B
|
[NCBI]
|
2.27387e-05
|
|
|
protoporphyria, erythropoietic
|
[NCBI]
|
2.24686e-05
|
|
|
CORD3
|
[NCBI]
|
2.21214e-05
|
|
|
legg-calve-perthes disease
|
[NCBI]
|
2.21214e-05
|
|
|
sturge-weber syndrome
|
[NCBI]
|
2.21214e-05
|
|
|
LSFC
|
[NCBI]
|
2.21214e-05
|
|
|
DFNB1
|
[NCBI]
|
2.20734e-05
|
|
|
HGF
|
[NCBI]
|
2.17556e-05
|
|
|
leber optic atrophy
|
[NCBI]
|
2.17406e-05
|
|
|
PRKCH
|
[NCBI]
|
2.16173e-05
|
|
|
CH25H
|
[NCBI]
|
2.16173e-05
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
2.15697e-05
|
|
|
MFS
|
[NCBI]
|
2.10584e-05
|
|
|
MBP
|
[NCBI]
|
2.02306e-05
|
|
|
PHF8
|
[NCBI]
|
2.01308e-05
|
|
|
proteinuria, low molecular weight, with hypercalciuria and nephrocalcinosis
|
[NCBI]
|
1.96823e-05
|
|
|
omphalocele
|
[NCBI]
|
1.96823e-05
|
|
|
hyperferritinemia-cataract syndrome
|
[NCBI]
|
1.96823e-05
|
|
|
creatine deficiency syndrome, x-linked
|
[NCBI]
|
1.96823e-05
|
|
|
prostate cancer/brain cancer susceptibility
|
[NCBI]
|
1.96823e-05
|
|
|
deafness, autosomal recessive
|
[NCBI]
|
1.96823e-05
|
|
|
antiphospholipid syndrome
|
[NCBI]
|
1.96823e-05
|
|
|
GALT
|
[NCBI]
|
1.96784e-05
|
|
|
HMBS
|
[NCBI]
|
1.96308e-05
|
|
|
homocysteinemia
|
[NCBI]
|
1.8994e-05
|
|
|
HSN2
|
[NCBI]
|
1.89496e-05
|
|
|
HSPA1L
|
[NCBI]
|
1.89496e-05
|
|
|
HD
|
[NCBI]
|
1.81899e-05
|
|
|
SMAX1
|
[NCBI]
|
1.80055e-05
|
|
|
chromosome 17q21.31 microdeletion syndrome
|
[NCBI]
|
1.79701e-05
|
|
|
HP
|
[NCBI]
|
1.77914e-05
|
|
|
OCA3
|
[NCBI]
|
1.76043e-05
|
|
|
aspirin resistance
|
[NCBI]
|
1.76043e-05
|
|
|
VLDLRCH
|
[NCBI]
|
1.76043e-05
|
|
|
PRPF31
|
[NCBI]
|
1.7134e-05
|
|
|
SDHA
|
[NCBI]
|
1.7134e-05
|
|
|
TNF
|
[NCBI]
|
1.70342e-05
|
|
|
CCR5
|
[NCBI]
|
1.67055e-05
|
|
|
EIG
|
[NCBI]
|
1.65739e-05
|
|
|
DRD4
|
[NCBI]
|
1.64084e-05
|
|
|
SACS
|
[NCBI]
|
1.64052e-05
|
|
|
EDNRA
|
[NCBI]
|
1.64052e-05
|
|
|
MBL2
|
[NCBI]
|
1.63404e-05
|
|
|
ARSA
|
[NCBI]
|
1.59793e-05
|
|
|
JWS
|
[NCBI]
|
1.58065e-05
|
|
|
schwannomatosis
|
[NCBI]
|
1.58065e-05
|
|
|
hepatitis b virus, susceptibility to
|
[NCBI]
|
1.58065e-05
|
|
|
afibrinogenemia, congenital
|
[NCBI]
|
1.58065e-05
|
|
|
SHANK3
|
[NCBI]
|
1.57595e-05
|
|
|
RAMP2
|
[NCBI]
|
1.57595e-05
|
|
|
klippel-trenaunay-weber syndrome
|
[NCBI]
|
1.55912e-05
|
|
|
CMD1A
|
[NCBI]
|
1.55457e-05
|
|
|
HPS
|
[NCBI]
|
1.54489e-05
|
|
|
MTTL1
|
[NCBI]
|
1.54358e-05
|
|
|
SHBG
|
[NCBI]
|
1.51441e-05
|
|
|
OCA2
|
[NCBI]
|
1.47819e-05
|
|
|
CILP
|
[NCBI]
|
1.46554e-05
|
|
|
TIMM8A
|
[NCBI]
|
1.46554e-05
|
|
|
PRNP
|
[NCBI]
|
1.44414e-05
|
|
|
SCZD2
|
[NCBI]
|
1.42326e-05
|
|
|
RP11
|
[NCBI]
|
1.42326e-05
|
|
|
coloboma, ocular
|
[NCBI]
|
1.42326e-05
|
|
|
cirrhosis, familial
|
[NCBI]
|
1.42326e-05
|
|
|
CLCN7
|
[NCBI]
|
1.41758e-05
|
|
|
malaria, susceptibility to
|
[NCBI]
|
1.40528e-05
|
|
|
DRD1
|
[NCBI]
|
1.37344e-05
|
|
|
ICOSLG
|
[NCBI]
|
1.37344e-05
|
|
|
MSR1
|
[NCBI]
|
1.37344e-05
|
|
|
glycogen storage disease ii
|
[NCBI]
|
1.34108e-05
|
|
|
amyloidosis vi
|
[NCBI]
|
1.33672e-05
|
|
|
OCA1A
|
[NCBI]
|
1.33565e-05
|
|
|
FOLR1
|
[NCBI]
|
1.33258e-05
|
|
|
NOTCH3
|
[NCBI]
|
1.33258e-05
|
|
|
PLA2G7
|
[NCBI]
|
1.33258e-05
|
|
|
CLEC4M
|
[NCBI]
|
1.33258e-05
|
|
|
HABP2
|
[NCBI]
|
1.33258e-05
|
|
|
BRCA1
|
[NCBI]
|
1.30582e-05
|
|
|
AGL
|
[NCBI]
|
1.29456e-05
|
|
|
TNFRSF25
|
[NCBI]
|
1.29456e-05
|
|
|
COCH
|
[NCBI]
|
1.29456e-05
|
|
|
PFC
|
[NCBI]
|
1.29456e-05
|
|
|
LGMD2H
|
[NCBI]
|
1.28416e-05
|
|
|
von willebrand disease, recessive form
|
[NCBI]
|
1.28416e-05
|
|
|
PPD2
|
[NCBI]
|
1.28416e-05
|
|
|
myotonia congenita, autosomal recessive
|
[NCBI]
|
1.28416e-05
|
|
|
LMNA
|
[NCBI]
|
1.28132e-05
|
|
|
homocystinuria due to deficiency of n(5,10)-methylenetetrahydrofolate reductase activity
|
[NCBI]
|
1.26912e-05
|
|
|
CEACAM5
|
[NCBI]
|
1.26166e-05
|
|
|
BMPR1A
|
[NCBI]
|
1.25903e-05
|
|
|
CYBA
|
[NCBI]
|
1.25903e-05
|
|
|
PLIN
|
[NCBI]
|
1.25903e-05
|
|
|
THBD
|
[NCBI]
|
1.25903e-05
|
|
|
ELAC2
|
[NCBI]
|
1.25903e-05
|
|
|
RNASEL
|
[NCBI]
|
1.22568e-05
|
|
|
USH2A
|
[NCBI]
|
1.22568e-05
|
|
|
GLDC
|
[NCBI]
|
1.19429e-05
|
|
|
IFNA1
|
[NCBI]
|
1.18778e-05
|
|
|
PQBP1
|
[NCBI]
|
1.16463e-05
|
|
|
PCCB
|
[NCBI]
|
1.16463e-05
|
|
|
SLC6A8
|
[NCBI]
|
1.16463e-05
|
|
|
wolff-parkinson-white syndrome
|
[NCBI]
|
1.1603e-05
|
|
|
RENS1
|
[NCBI]
|
1.1603e-05
|
|
|
crouzon syndrome
|
[NCBI]
|
1.1603e-05
|
|
|
pearson marrow-pancreas syndrome
|
[NCBI]
|
1.1603e-05
|
|
|
chromosome 22q13.3 deletion syndrome
|
[NCBI]
|
1.1603e-05
|
|
|
POAG
|
[NCBI]
|
1.14468e-05
|
|
|
SCA2
|
[NCBI]
|
1.1152e-05
|
|
|
FLT3
|
[NCBI]
|
1.10988e-05
|
|
|
RTT
|
[NCBI]
|
1.10395e-05
|
|
|
MODY
|
[NCBI]
|
1.09045e-05
|
|
|
DBH
|
[NCBI]
|
1.0845e-05
|
|
|
F12
|
[NCBI]
|
1.0845e-05
|
|
|
SLC5A5
|
[NCBI]
|
1.0845e-05
|
|
|
CAPN10
|
[NCBI]
|
1.0603e-05
|
|
|
PLAT
|
[NCBI]
|
1.0603e-05
|
|
|
RPE65
|
[NCBI]
|
1.0603e-05
|
|
|
SDHD
|
[NCBI]
|
1.0603e-05
|
|
|
diabetes insipidus, nephrogenic, autosomal
|
[NCBI]
|
1.04933e-05
|
|
|
trichodentoosseous syndrome
|
[NCBI]
|
1.04933e-05
|
|
|
JME
|
[NCBI]
|
1.04933e-05
|
|
|
amyotrophic lateral sclerosis-parkinsonism/dementia complex 1
|
[NCBI]
|
1.04933e-05
|
|
|
tetralogy of fallot
|
[NCBI]
|
1.04933e-05
|
|
|
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal recessive
|
[NCBI]
|
1.04933e-05
|
|
|
ACHM2
|
[NCBI]
|
1.04933e-05
|
|
|
kaposi sarcoma
|
[NCBI]
|
1.04933e-05
|
|
|
ISS
|
[NCBI]
|
1.04933e-05
|
|
|
complement component 7 deficiency
|
[NCBI]
|
1.04933e-05
|
|
|
NFNS
|
[NCBI]
|
1.04933e-05
|
|
|
ACH
|
[NCBI]
|
1.03901e-05
|
|
|
PINK1
|
[NCBI]
|
1.03718e-05
|
|
|
AD
|
[NCBI]
|
1.03475e-05
|
|
|
BRCA2
|
[NCBI]
|
1.00577e-05
|
|
|
BMP15
|
[NCBI]
|
9.93831e-06
|
|
|
AICDA
|
[NCBI]
|
9.53886e-06
|
|
|
DYT1
|
[NCBI]
|
9.53886e-06
|
|
|
IFNGR1
|
[NCBI]
|
9.53886e-06
|
|
|
EV
|
[NCBI]
|
9.49835e-06
|
|
|
MS
|
[NCBI]
|
9.49835e-06
|
|
|
vitamin d-dependent rickets, type i
|
[NCBI]
|
9.49394e-06
|
|
|
leprosy, susceptibility to
|
[NCBI]
|
9.49394e-06
|
|
|
alpha-thalassemia/mental retardation syndrome, deletion-type
|
[NCBI]
|
9.49394e-06
|
|
|
SOST
|
[NCBI]
|
9.49394e-06
|
|
|
PITX2
|
[NCBI]
|
9.3504e-06
|
|
|
SMPD1
|
[NCBI]
|
9.3504e-06
|
|
|
PON1
|
[NCBI]
|
9.25217e-06
|
|
|
PROS1
|
[NCBI]
|
9.16878e-06
|
|
|
MAFD6
|
[NCBI]
|
9.11876e-06
|
|
|
TNFSF6
|
[NCBI]
|
9.0899e-06
|
|
|
DRPLA
|
[NCBI]
|
9.04546e-06
|
|
|
DPYD
|
[NCBI]
|
8.99357e-06
|
|
|
thrombasthenia of glanzmann and naegeli
|
[NCBI]
|
8.83843e-06
|
|
|
fructose intolerance, hereditary
|
[NCBI]
|
8.82435e-06
|
|
|
MEFV
|
[NCBI]
|
8.82435e-06
|
|
|
CETP
|
[NCBI]
|
8.82435e-06
|
|
|
SMAD4
|
[NCBI]
|
8.82435e-06
|
|
|
ENPP1
|
[NCBI]
|
8.66077e-06
|
|
|
HLA-B
|
[NCBI]
|
8.66077e-06
|
|
|
oca2 gene
|
[NCBI]
|
8.66077e-06
|
|
|
MTND6
|
[NCBI]
|
8.66077e-06
|
|
|
RECQL3
|
[NCBI]
|
8.66077e-06
|
|
|
PARK6
|
[NCBI]
|
8.59022e-06
|
|
|
helicobacter pylori infection, susceptibility to
|
[NCBI]
|
8.59022e-06
|
|
|
pseudoxanthoma elasticum, forme fruste
|
[NCBI]
|
8.59022e-06
|
|
|
HSAN2
|
[NCBI]
|
8.59022e-06
|
|
|
SAA1
|
[NCBI]
|
8.5025e-06
|
|
|
CLCN1
|
[NCBI]
|
8.5025e-06
|
|
|
PPOX
|
[NCBI]
|
8.34922e-06
|
|
|
RNASE3
|
[NCBI]
|
8.34006e-06
|
|
|
TTR
|
[NCBI]
|
8.31745e-06
|
|
|
ACADM
|
[NCBI]
|
8.24255e-06
|
|
|
OA1
|
[NCBI]
|
8.20068e-06
|
|
|
aspartylglucosaminuria
|
[NCBI]
|
8.20068e-06
|
|
|
FGFR2
|
[NCBI]
|
8.18737e-06
|
|
|
XPA
|
[NCBI]
|
7.91675e-06
|
|
|
ACADS
|
[NCBI]
|
7.91675e-06
|
|
|
glycogen storage disease i
|
[NCBI]
|
7.91675e-06
|
|
|
SLC26A4
|
[NCBI]
|
7.91675e-06
|
|
|
FGG
|
[NCBI]
|
7.91675e-06
|
|
|
RS1
|
[NCBI]
|
7.78092e-06
|
|
|
PDE6B
|
[NCBI]
|
7.78092e-06
|
|
|
neural tube defects, folate-sensitive
|
[NCBI]
|
7.77016e-06
|
|
|
HPC1
|
[NCBI]
|
7.77016e-06
|
|
|
SLOS
|
[NCBI]
|
7.66079e-06
|
|
|
DSG1
|
[NCBI]
|
7.6489e-06
|
|
|
GAMT
|
[NCBI]
|
7.6489e-06
|
|
|
NOD2
|
[NCBI]
|
7.6489e-06
|
|
|
DES
|
[NCBI]
|
7.52051e-06
|
|
|
SMN2
|
[NCBI]
|
7.52051e-06
|
|
|
GAA
|
[NCBI]
|
7.39558e-06
|
|
|
ABCA4
|
[NCBI]
|
7.27394e-06
|
|
|
SCN4A
|
[NCBI]
|
7.15545e-06
|
|
|
ENG
|
[NCBI]
|
7.03997e-06
|
|
|
DBA
|
[NCBI]
|
7.03591e-06
|
|
|
giant platelet syndrome
|
[NCBI]
|
7.03591e-06
|
|
|
properdin deficiency, x-linked
|
[NCBI]
|
7.0239e-06
|
|
|
factor xii deficiency
|
[NCBI]
|
7.0239e-06
|
|
|
HNPP
|
[NCBI]
|
7.02064e-06
|
|
|
NF2
|
[NCBI]
|
7.02064e-06
|
|
|
sickle cell anemia
|
[NCBI]
|
7.02064e-06
|
|
|
DAZ
|
[NCBI]
|
6.92736e-06
|
|
|
KAL1
|
[NCBI]
|
6.92736e-06
|
|
|
APCS
|
[NCBI]
|
6.71028e-06
|
|
|
PCD
|
[NCBI]
|
6.55218e-06
|
|
|
TBG
|
[NCBI]
|
6.4034e-06
|
|
|
PCLD
|
[NCBI]
|
6.34323e-06
|
|
|
brugada syndrome 1
|
[NCBI]
|
6.34323e-06
|
|
|
KAL2
|
[NCBI]
|
6.34323e-06
|
|
|
IBM2
|
[NCBI]
|
6.34323e-06
|
|
|
F13A1
|
[NCBI]
|
6.21019e-06
|
|
|
CYP2D6
|
[NCBI]
|
6.21019e-06
|
|
|
CDLS1
|
[NCBI]
|
6.15046e-06
|
|
|
UNG
|
[NCBI]
|
6.11675e-06
|
|
|
AGT
|
[NCBI]
|
6.11675e-06
|
|
|
AS
|
[NCBI]
|
6.09296e-06
|
|
|
PROCR
|
[NCBI]
|
6.0253e-06
|
|
|
ITGB2
|
[NCBI]
|
6.0253e-06
|
|
|
PSEN2
|
[NCBI]
|
5.7623e-06
|
|
|
PLOSL
|
[NCBI]
|
5.72123e-06
|
|
|
EPO
|
[NCBI]
|
5.70207e-06
|
|
|
FMR1
|
[NCBI]
|
5.66481e-06
|
|
|
SLC11A1
|
[NCBI]
|
5.51497e-06
|
|
|
KRAS
|
[NCBI]
|
5.43574e-06
|
|
|
MTND4
|
[NCBI]
|
5.43574e-06
|
|
|
PKD2
|
[NCBI]
|
5.43574e-06
|
|
|
HNF4A
|
[NCBI]
|
5.43574e-06
|
|
|
phenylketonuria
|
[NCBI]
|
5.41247e-06
|
|
|
NF2
|
[NCBI]
|
5.35804e-06
|
|
|
ITGB3
|
[NCBI]
|
5.35804e-06
|
|
|
AR
|
[NCBI]
|
5.27349e-06
|
|
|
PLG
|
[NCBI]
|
5.27332e-06
|
|
|
RP
|
[NCBI]
|
5.22397e-06
|
|
|
CF
|
[NCBI]
|
5.20832e-06
|
|
|
IRS1
|
[NCBI]
|
5.20702e-06
|
|
|
histidinemia
|
[NCBI]
|
5.15203e-06
|
|
|
ETM1
|
[NCBI]
|
5.15203e-06
|
|
|
gm1-gangliosidosis, type i
|
[NCBI]
|
5.15203e-06
|
|
|
protein c deficiency, congenital thrombotic disease due to
|
[NCBI]
|
4.92129e-06
|
|
|
temporal arteritis
|
[NCBI]
|
4.82252e-06
|
|
|
VCP
|
[NCBI]
|
4.59165e-06
|
|
|
FSHR
|
[NCBI]
|
4.59165e-06
|
|
|
SLC4A1
|
[NCBI]
|
4.52906e-06
|
|
|
MAS
|
[NCBI]
|
4.49585e-06
|
|
|
PAX6
|
[NCBI]
|
4.46751e-06
|
|
|
TS
|
[NCBI]
|
4.4614e-06
|
|
|
PARK2
|
[NCBI]
|
4.40698e-06
|
|
|
APOA1
|
[NCBI]
|
4.34744e-06
|
|
|
RYR1
|
[NCBI]
|
4.34744e-06
|
|
|
myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency
|
[NCBI]
|
4.15257e-06
|
|
|
glycogen storage disease iii
|
[NCBI]
|
4.15257e-06
|
|
|
USH2A
|
[NCBI]
|
4.15257e-06
|
|
|
dystrophia myotonica 1
|
[NCBI]
|
4.01039e-06
|
|
|
STAT6
|
[NCBI]
|
4.00967e-06
|
|
|
VHL
|
[NCBI]
|
3.85232e-06
|
|
|
UCP3
|
[NCBI]
|
3.75133e-06
|
|
|
JMML
|
[NCBI]
|
3.73411e-06
|
|
|
CRMO
|
[NCBI]
|
3.71419e-06
|
|
|
alcohol dependence
|
[NCBI]
|
3.71419e-06
|
|
|
SPP1
|
[NCBI]
|
3.66381e-06
|
|
|
GBA
|
[NCBI]
|
3.65332e-06
|
|
|
PI
|
[NCBI]
|
3.57433e-06
|
|
|
SMN1
|
[NCBI]
|
3.55816e-06
|
|
|
WRN
|
[NCBI]
|
3.55124e-06
|
|
|
prostate cancer
|
[NCBI]
|
3.51347e-06
|
|
|
MEN1
|
[NCBI]
|
3.46571e-06
|
|
|
BLM
|
[NCBI]
|
3.37154e-06
|
|
|
TLR4
|
[NCBI]
|
3.24563e-06
|
|
|
IL4
|
[NCBI]
|
3.16204e-06
|
|
|
KRT20
|
[NCBI]
|
3.08055e-06
|
|
|
TYR
|
[NCBI]
|
3.08055e-06
|
|
|
porphyria variegata
|
[NCBI]
|
3.0434e-06
|
|
|
GNRH1
|
[NCBI]
|
3.03495e-06
|
|
|
SCZD
|
[NCBI]
|
2.99188e-06
|
|
|
diabetes insipidus, nephrogenic, x-linked
|
[NCBI]
|
2.94352e-06
|
|
|
lung cancer
|
[NCBI]
|
2.94352e-06
|
|
|
osteoarthritis
|
[NCBI]
|
2.94352e-06
|
|
|
AFP
|
[NCBI]
|
2.9338e-06
|
|
|
FTD
|
[NCBI]
|
2.86838e-06
|
|
|
FBN1
|
[NCBI]
|
2.70423e-06
|
|
|
OFC1
|
[NCBI]
|
2.68908e-06
|
|
|
INS
|
[NCBI]
|
2.65903e-06
|
|
|
MG
|
[NCBI]
|
2.64629e-06
|
|
|
velocardiofacial syndrome
|
[NCBI]
|
2.61646e-06
|
|
|
FHM1
|
[NCBI]
|
2.60575e-06
|
|
|
ABCC8
|
[NCBI]
|
2.56689e-06
|
|
|
CMH
|
[NCBI]
|
2.50498e-06
|
|
|
ESR1
|
[NCBI]
|
2.5008e-06
|
|
|
NPM1
|
[NCBI]
|
2.43634e-06
|
|
|
CFH
|
[NCBI]
|
2.43634e-06
|
|
|
PKD1
|
[NCBI]
|
2.40471e-06
|
|
|
UCP2
|
[NCBI]
|
2.40471e-06
|
|
|
PWS
|
[NCBI]
|
2.40456e-06
|
|
|
osteogenesis imperfecta, type i
|
[NCBI]
|
2.36485e-06
|
|
|
POMC
|
[NCBI]
|
2.3306e-06
|
|
|
MAPT
|
[NCBI]
|
2.31214e-06
|
|
|
musical perfect pitch
|
[NCBI]
|
2.29655e-06
|
|
|
usher syndrome, type i
|
[NCBI]
|
2.29655e-06
|
|
|
SPDA1
|
[NCBI]
|
2.29655e-06
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
2.02608e-06
|
|
|
AVSD
|
[NCBI]
|
1.88145e-06
|
|
|
PRL
|
[NCBI]
|
1.87543e-06
|
|
|
RHO
|
[NCBI]
|
1.87141e-06
|
|
|
STL1
|
[NCBI]
|
1.75588e-06
|
|
|
AGER
|
[NCBI]
|
1.7033e-06
|
|
|
BCNS
|
[NCBI]
|
1.6873e-06
|
|
|
MECP2
|
[NCBI]
|
1.63532e-06
|
|
|
ABCB1
|
[NCBI]
|
1.63532e-06
|
|
|
asthma, susceptibility to
|
[NCBI]
|
1.63027e-06
|
|
|
ALS1
|
[NCBI]
|
1.63027e-06
|
|
|
IBD1
|
[NCBI]
|
1.56868e-06
|
|
|
F3
|
[NCBI]
|
1.56818e-06
|
|
|
COMT
|
[NCBI]
|
1.55675e-06
|
|
|
DGS
|
[NCBI]
|
1.53438e-06
|
|
|
FPLD2
|
[NCBI]
|
1.52094e-06
|
|
|
hypogonadotropic hypogonadism
|
[NCBI]
|
1.49608e-06
|
|
|
PLTP
|
[NCBI]
|
1.36627e-06
|
|
|
ADA
|
[NCBI]
|
1.36354e-06
|
|
|
CFTR
|
[NCBI]
|
1.34447e-06
|
|
|
gastric cancer
|
[NCBI]
|
1.30757e-06
|
|
|
PSEN1
|
[NCBI]
|
1.29116e-06
|
|
|
metachromatic leukodystrophy
|
[NCBI]
|
1.24143e-06
|
|
|
hemophilia a
|
[NCBI]
|
1.21937e-06
|
|
|
apc gene
|
[NCBI]
|
1.20192e-06
|
|
|
APP
|
[NCBI]
|
1.11756e-06
|
|
|
mitochondrial complex iv deficiency
|
[NCBI]
|
1.1144e-06
|
|
|
PGL1
|
[NCBI]
|
1.1144e-06
|
|
|
BBS
|
[NCBI]
|
1.10847e-06
|
|
|
HEMB
|
[NCBI]
|
1.02241e-06
|
|
|
KSS
|
[NCBI]
|
9.55684e-07
|
|
|
EVA
|
[NCBI]
|
9.40227e-07
|
|
|
SOD2
|
[NCBI]
|
8.74118e-07
|
|
|
ACE
|
[NCBI]
|
8.55346e-07
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
8.28522e-07
|
|
|
drug metabolism, poor, cyp2d6-related
|
[NCBI]
|
7.8392e-07
|
|
|
CADASIL
|
[NCBI]
|
7.8392e-07
|
|
|
MPO
|
[NCBI]
|
7.70263e-07
|
|
|
WBS
|
[NCBI]
|
7.28792e-07
|
|
|
OPA1
|
[NCBI]
|
6.44463e-07
|
|
|
CRC
|
[NCBI]
|
6.16942e-07
|
|
|
CVID
|
[NCBI]
|
5.90358e-07
|
|
|
PPARA
|
[NCBI]
|
5.84243e-07
|
|
|
JAK2
|
[NCBI]
|
5.50026e-07
|
|
|
LFS1
|
[NCBI]
|
5.20918e-07
|
|
|
CYP1A1
|
[NCBI]
|
5.0273e-07
|
|
|
TLR2
|
[NCBI]
|
4.92899e-07
|
|
|
PDS
|
[NCBI]
|
4.12426e-07
|
|
|
GLC1A
|
[NCBI]
|
4.12426e-07
|
|
|
CTNS
|
[NCBI]
|
4.12426e-07
|
|
|
mucolipidosis ii
|
[NCBI]
|
4.12426e-07
|
|
|
wilson disease
|
[NCBI]
|
4.04241e-07
|
|
|
melanoma, uveal
|
[NCBI]
|
3.18194e-07
|
|
|
FGF7
|
[NCBI]
|
3.15736e-07
|
|
|
APC
|
[NCBI]
|
2.96519e-07
|
|
|
NPC1
|
[NCBI]
|
2.84761e-07
|
|
|
HBB
|
[NCBI]
|
2.48407e-07
|
|
|
hypercholesterolemia, autosomal dominant
|
[NCBI]
|
2.39546e-07
|
|
|
FGFR3
|
[NCBI]
|
2.34645e-07
|
|
|
hurler syndrome
|
[NCBI]
|
2.2264e-07
|
|
|
HBA1
|
[NCBI]
|
1.81362e-07
|
|
|
ADM
|
[NCBI]
|
1.76478e-07
|
|
|
GHR
|
[NCBI]
|
1.76478e-07
|
|
|
TFPI
|
[NCBI]
|
1.76093e-07
|
|
|
TP53
|
[NCBI]
|
1.48803e-07
|
|
|
ARPKD
|
[NCBI]
|
1.19689e-07
|
|
|
HAE
|
[NCBI]
|
1.1402e-07
|
|
|
SCA7
|
[NCBI]
|
7.94146e-08
|
|
|
WS1
|
[NCBI]
|
7.94146e-08
|
|
|
TNFRSF11B
|
[NCBI]
|
7.54677e-08
|
|
|
porphyria, acute intermittent
|
[NCBI]
|
7.00407e-08
|
|
|
RTS
|
[NCBI]
|
7.00407e-08
|
|
|
JPS
|
[NCBI]
|
7.00407e-08
|
|
|
XPA
|
[NCBI]
|
7.00407e-08
|
|
|
OPMD
|
[NCBI]
|
6.77411e-08
|
|
|
CCM
|
[NCBI]
|
4.70042e-08
|
|
|
AN2
|
[NCBI]
|
4.70042e-08
|
|
|
LAD
|
[NCBI]
|
3.71641e-08
|
|
|
SLC6A3
|
[NCBI]
|
3.27039e-08
|
|
|
fabry disease
|
[NCBI]
|
2.97898e-08
|
|
|
CP
|
[NCBI]
|
2.50343e-08
|
|
|
polycystic kidneys
|
[NCBI]
|
1.92119e-08
|
|
|
DYT1
|
[NCBI]
|
1.48854e-08
|
|
|
SCS
|
[NCBI]
|
1.48854e-08
|
|
|
SCIDX1
|
[NCBI]
|
1.48854e-08
|
|
|
galactosemia
|
[NCBI]
|
7.07995e-09
|
|
|
SCA1
|
[NCBI]
|
5.08349e-09
|
|
|
LWD
|
[NCBI]
|
2.73397e-09
|
|
|
FFI
|
[NCBI]
|
6.34887e-10
|
|
|
NPS
|
[NCBI]
|
2.69489e-10
|
|